Showing results (61-70 of 143) with videos related to

Sort By:
Pageof 15
ACS Nano|March 2, 2019
Intrinsic Antibacterial Activity of Nanoparticles Made of β-Cyclodextrins Potentiates Their Effect as Drug Nanocarriers against TuberculosisArnaud Machelart, Giuseppina Salzano, Xue Li, et al.
Nature Medicine|April 15, 2003
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosisAlexander S Pym, Priscille Brodin, Laleh Majlessi, et al.
Plos One|November 29, 2018
Theaflavins, polyphenols of black tea, inhibit entry of hepatitis C virus in cell culturePritom Chowdhury, Marie-Emmanuelle Sahuc, Yves Rouillé, et al.
Microbial Genomics|February 2, 2021
Pathogenomic analyses of Mycobacterium microti, an ESX-1-deleted member of the Mycobacterium tuberculosis complex causing disease in various hostsMickael Orgeur, Wafa Frigui, Alexandre Pawlik, et al.
Antimicrobial Agents and Chemotherapy|July 11, 2018
Synergy between Circular Bacteriocin AS-48 and Ethambutol against Mycobacterium tuberculosisClara Aguilar-Pérez, Begoña Gracia, Liliana Rodrigues, et al.
Antimicrobial Agents and Chemotherapy|October 29, 2014
High-content screening technology combined with a human granuloma model as a new approach to evaluate the activities of drugs against Mycobacterium tuberculosisMayra Silva-Miranda, Euloge Ekaza, Adrien Breiman, et al.
Cell Host & Microbe|September 5, 2017
Legionella pneumophila Modulates Mitochondrial Dynamics to Trigger Metabolic Repurposing of Infected MacrophagesPedro Escoll, Ok-Ryul Song, Flávia Viana, et al.
Frontiers in Pharmacology|April 30, 2019
Mycolactone as Analgesic: Subcutaneous Bioavailability ParametersJérémie Babonneau, Dimitri Bréard, Marie-Line Reynaert, et al.
Infection and Immunity|March 23, 2006
An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosisLaleh Majlessi, Marcela Simsova, Zdenka Jarvis, et al.
Frontiers in Cellular and Infection Microbiology|March 20, 2023
An image-based high-content screening for compounds targeting Toxoplasma gondii repurposed inhibitors effective against the malaria parasite Plasmodium falciparumAriane Honfozo, Rodrigue Houngue, Alexandre Vandeputte, et al.
Pageof 15